Prosecution Insights
Last updated: August 18, 2026

Examiner: EIX, EMILY FAY

Tech Center 1700 • Art Units: 1651 1653 1796

This examiner grants 47% of resolved cases

Performance Statistics

46.7%
Allow Rate
-18.3% vs TC avg
95
Total Applications
+76.2%
Interview Lift
1279
Avg Prosecution Days
Based on 30 resolved cases, 2023–2026

Rejection Statute Breakdown

3.9%
§101 Eligibility
22.0%
§102 Novelty
36.0%
§103 Obviousness
23.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18026860 METHOD FOR RECOVERING A PROTEIN FROM A FERMENTATION BROTH COMPRISING A HIGH DEGREE OF LYSED CELLS Final Rejection BASF SE
18173620 WASHING OR CLEANING AGENT COMPRISING A PROTEASE AND AN AMYLASE Final Rejection BASF SE
18559244 METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC PROSTATITIS AND/OR CHRONIC PELVIC PAIN SYNDROME Non-Final OA NORTHWESTERN UNIVERSITY
18005826 ENGINEERED N-GLYCOSYLTRANSFERASES WITH ALTERED SPECIFICITIES Final Rejection Northwestern University
18259153 ENZYMATIC RECYCLING OF POLYURETHANES BY A COMBINATION OF CUTINASES AND ESTERASES Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18012916 NOVEL METHOD OF MEASURING ENZYME ACTIVITY Non-Final OA CJ CHEILJEDANG CORPORATION
17915405 CELL CAPSULATING LAYER, CAPSULATED CELLS, CELL CAPSULATING COMPOSITION AND PREPARATION METHOD THEREFOR Final Rejection SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18695470 A FERMENTATION MEDIUM COMPRISING SULPHUR Non-Final OA Evonik Operations GmbH
18267189 LIGAND-BINDING POLYPEPTIDES AND USES THEREOF Non-Final OA CAMBRIDGE ENTERPRISE LIMITED
18229592 USE OF INTESTINAL PROBIOTIC IN PREPARATION OF MEDICAMENT THAT PROMOTES METABOLISM OF ELLAGIC ACID INTO UROLITHIN A, PHARMACEUTICAL COMPOSITION AND USE THEREOF Final Rejection Zhejiang University
18529611 METHODS FOR TREATING LYSOSOMAL STORAGE DISEASES Non-Final OA Rutgers, The State University of New Jersey
18708496 MUTANT ACE2 PROTEINS AND METHODS OF USING SAME Non-Final OA Wisconsin Alumni Research Foundation
18553310 CHONDROITIN-PRODUCING RECOMBINANT CELL Non-Final OA GIVAUDAN SA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month